ATE295732T1 - Verwendung von n-substituierten 1,5-dideoxy-1,5- imino-d-glucitol verbindungen in der kombinationstherapie der vom hepatitisvirus verursachten infektionen - Google Patents

Verwendung von n-substituierten 1,5-dideoxy-1,5- imino-d-glucitol verbindungen in der kombinationstherapie der vom hepatitisvirus verursachten infektionen

Info

Publication number
ATE295732T1
ATE295732T1 AT98906475T AT98906475T ATE295732T1 AT E295732 T1 ATE295732 T1 AT E295732T1 AT 98906475 T AT98906475 T AT 98906475T AT 98906475 T AT98906475 T AT 98906475T AT E295732 T1 ATE295732 T1 AT E295732T1
Authority
AT
Austria
Prior art keywords
dideoxy
imino
substituted
hepatitis virus
combination therapy
Prior art date
Application number
AT98906475T
Other languages
English (en)
Inventor
Gary S Jacob
Timothy M Block
Raymond A Dwek
Original Assignee
Searle Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle Llc filed Critical Searle Llc
Application granted granted Critical
Publication of ATE295732T1 publication Critical patent/ATE295732T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98906475T 1997-02-14 1998-02-12 Verwendung von n-substituierten 1,5-dideoxy-1,5- imino-d-glucitol verbindungen in der kombinationstherapie der vom hepatitisvirus verursachten infektionen ATE295732T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4122197P 1997-02-14 1997-02-14
PCT/US1998/003004 WO1998035685A1 (en) 1997-02-14 1998-02-12 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections

Publications (1)

Publication Number Publication Date
ATE295732T1 true ATE295732T1 (de) 2005-06-15

Family

ID=21915395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98906475T ATE295732T1 (de) 1997-02-14 1998-02-12 Verwendung von n-substituierten 1,5-dideoxy-1,5- imino-d-glucitol verbindungen in der kombinationstherapie der vom hepatitisvirus verursachten infektionen

Country Status (8)

Country Link
EP (1) EP1007058B1 (de)
JP (1) JP2001512462A (de)
CN (1) CN100382804C (de)
AT (1) ATE295732T1 (de)
AU (1) AU6169298A (de)
DE (1) DE69830241T2 (de)
ES (1) ES2244048T3 (de)
WO (1) WO1998035685A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
DK1030839T3 (da) 1997-11-10 2004-05-03 Searle & Co Anvendelse af alkylerede iminosukkere til behandling af multidrugresistens
US6465488B1 (en) 1997-12-11 2002-10-15 Chancellor, Masters & Scholars Of The University Of Oxford Inhibition of glycolipid biosynthesis
WO1999029321A1 (en) * 1997-12-11 1999-06-17 The Chancellor, Masters And Scholars Of The University Of Oxford Inhibition of membrane-associated viral replication
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
US6809083B1 (en) * 1998-02-12 2004-10-26 Richard A. Mueller Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
EP1714676A3 (de) * 1998-02-12 2006-11-15 G.D. Searle LLC. N-substituierte 1,5-dideoxy-1,5-imino-D-glucitol Verbindungen für die Therapie von Hepatitis Virus Infektionen
ATE402701T1 (de) 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
JP2003505501A (ja) 1999-02-12 2003-02-12 ジー・ディー・サール・アンド・カンパニー 肝炎ウィルス感染の処置のためのグルカミン化合物
EP1658846B1 (de) * 1999-02-12 2008-07-30 United Therapeutics Corporation N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen
US7256005B2 (en) 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
ES2302697T3 (es) * 1999-08-10 2008-08-01 The Chancellor, Masters And Scholars Of The University Of Oxford Compuestos n-alquilicos de cadena larga y derivados oxa de los mismos y uso como composiciones antivirales.
EP1261339A1 (de) * 2000-02-14 2002-12-04 Pharmacia Corporation Verwendung von n-substituierten 1,5-dideoxy-1,5-imino-d-glucitolverbindungen zur behandlung von hepatitisvirusinfektionen
EP1556036A2 (de) * 2002-09-23 2005-07-27 The Chancellor, Masters And Scholars Of The University Of Oxford Verwendung von iminozuckerderivaten zur inhibierung der ionenkanalaktivität
AU2019339777B2 (en) 2018-09-12 2022-09-01 Novartis Ag Antiviral pyridopyrazinedione compounds
US11667613B2 (en) 2019-09-26 2023-06-06 Novartis Ag Antiviral pyrazolopyridinone compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006061A1 (en) * 1993-08-20 1995-03-02 G.D. Searle & Co. Retroviral protease inhibitors and combinations thereof

Also Published As

Publication number Publication date
HK1027509A1 (en) 2001-01-19
EP1007058A1 (de) 2000-06-14
AU6169298A (en) 1998-09-08
WO1998035685A1 (en) 1998-08-20
CN100382804C (zh) 2008-04-23
DE69830241T2 (de) 2006-01-26
EP1007058B1 (de) 2005-05-18
CN1251993A (zh) 2000-05-03
JP2001512462A (ja) 2001-08-21
ES2244048T3 (es) 2005-12-01
DE69830241D1 (de) 2005-06-23

Similar Documents

Publication Publication Date Title
EA200000836A1 (ru) Применение n-замещенных 1,5-дидезокси-1,5-имино-d-глюцитных производных для лечения инфекций, вызываемых вирусами гепатита
DE69830241D1 (de) Verwendung von n-substituierten 1,5-dideoxy-1,5-imino-d-glucitol verbindungen in der kombinationstherapie der vom hepatitisvirus verursachten infektionen
ATE402701T1 (de) N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
KR0179637B1 (en) Diaromatic substituted compounds as anti-hiv-1 agents
ID26956A (id) Pencegahan raf kinase menggunakan simetris dan nonsimetris yang digantikan diphenil urea
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
ATE199906T1 (de) Phosphonat-nukleotid ester-derivate
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
DE60037664D1 (de) Langkettige n-alkyl verbindungen und deren oxa-derivate zur verwendung als anitvirale mittel
HU9401676D0 (en) Pharmaceutical agents for treatment of emesis
ATE265535T1 (de) Pharmazeutische zusammensetzung gegen durch papillomaviren verursachte tumoren und infektionen
EP0656791A4 (de) Therapeutische zusammensetzungen und verfahren unter verwendung von pqq.
ATE77234T1 (de) Aromatische verbindungen mit amider struktur, derivate von aminobenzoesaeuren, hydroxybenzoesaeuren, zimtsaeuren, urocansaeuren und benzimidazolen, die uvb und/oder uva absorbieren.
NO890046D0 (no) Disubstituerte pyridiner.
ATE76579T1 (de) Interferon-zusammensetzungen.
ES2102772T3 (es) Compuesto citotoxico y antiviral.
ATE383161T1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
ATE59777T1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
PY0101564A (es) Triazine containing anionic compounds useful as antiviral agents
AR024537A1 (es) Combinacion sinergica para el tratamiento de enfermedades mediadas virales
ATE242253T1 (de) Verbindungen die als antiproliferierende mittel und garft inhibitoren verwendbar sind
AR019532A1 (es) COMPOSICIoN FARMACÉUTICA DEL COMPUESTO 1,5-DIDEOXI-1,5-IMIN-D-GLUCITOL N-SUSTITUIDO
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.
DK0412941T3 (da) Phospholipider til behandling af dissemineret sklerose
KR960021043A (ko) 스코폴레틴을 포함하는 b형 간염 치료제

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties